Skip to main content
Clinical Trials/NCT00820729
NCT00820729
Completed
Not Applicable

The Prevalence of Pulmonary Hypertension and the Significance of Different Biomarkers in Chronic Interstitial Lung Disease

University of Aarhus2 sites in 1 country212 target enrollmentMarch 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interstitial Lung Disease
Sponsor
University of Aarhus
Enrollment
212
Locations
2
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The presence of an abnormally increased pulmonary blood pressure worsens the prognosis of patients with interstitial pulmonary disease.

The aim of this study is to estimate the frequency of an increased blood pressure in the lungs among patient with interstitial pulmonary disease, and to evaluate the use of different biomarkers in diagnosis of the condition.

Detailed Description

The presence of increased pulmonary blood pressure is established by echocardiography and confirmed by right heart catheterization. The ability of NT-proBNP, vWf, troponin-t, D-dimer and exhaled NO to predict the presence of increased pressure in the pulmonary circulation is evaluated.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
March 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charlotte Andersen

MD

University of Aarhus

Eligibility Criteria

Inclusion Criteria

  • Interstitial pulmonary disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials